Quick Takeaways
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G/A for Phathom Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PHAT).
- Disclosed ownership: 5.9%.
- Date of event: 19 Aug 2025.
MILLENNIUM MANAGEMENT LLC - 19 Aug 2025 SCHEDULE 13G/A Report for Phathom Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PHAT)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- PHAT
- Shares outstanding
- 70,517,203 shares
- Disclosed Ownership
- 4,160,515 shares
- Ownership
- 5.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 25 Aug 2025, 16:12:48 UTC
- Date of event
- 19 Aug 2025
- Previous filing
- 13 Aug 2025
- Next filing
- 03 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MILLENNIUM MANAGEMENT LLC disclosed 5.9% ownership in Phathom Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PHAT) on 19 Aug 2025."
What Changed
- Previous schedule filing date: 13 Aug 2025.
- Current filing was accepted on 25 Aug 2025, 16:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 5.1% | 3,588,650 | 0 | 3,588,650 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 5.9% | 4,160,515 | 0 | 4,160,515 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 5.9% | 4,160,515 | 0 | 4,160,515 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 5.9% | 4,160,515 | 0 | 4,160,515 | /s/ Israel A. Englander | Israel A. Englander |